SPRB vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

SPRB

26.1
AI Score
VS
CBIO Wins

CBIO

42.6
AI Score

Investment Advisor Scores

SPRB

26score
Recommendation
EXTENDED

CBIO

43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric SPRB CBIO Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -75.9% 0.0% CBIO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 26.1/100 42.6/100 CBIO
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED HOLD Tie

Relative Price Performance (Last 90 Days)

SPRB 1M: +28.8% · 3M: +8.7% CBIO 1M: +4.6% · 3M: -17.8%

Current Technical Phase

SPRB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 71

RSI (14): 70.9 · Price: $55.50

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 52.7 · Price: $17.05

Fundamentals Snapshot

Metric SPRB CBIO
Market Cap
Forward P/E 6.5 -6.5
Trailing P/E
Revenue (TTM)
Revenue Growth -0.8% 0.0%
Gross Margin -32.9% 1.0%
Operating Margin 0.0% -14.3%
EPS -35.82 -0.13
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.